Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed +172.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed +519.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -33.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -55.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +206.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +47.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +34.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -53.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -47.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +40.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +30.1% from the comparable as-filed period. The change ranks at the 94th percentile of 101 prior comparable changes.
Research & development changed +91.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -34.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -41.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.